Population-Based PBPK Model for the Prediction of Time-Variant Bile Salt Disposition within GI Luminal Fluids
- PMID: 32176503
- DOI: 10.1021/acs.molpharmaceut.0c00019
Population-Based PBPK Model for the Prediction of Time-Variant Bile Salt Disposition within GI Luminal Fluids
Abstract
In vivo studies have shown cyclic bile salt (BS) outputs during fasting whereas higher amounts have been observed in fed states. This leads to fluctuations of intestinal BS concentrations ([BS]) that can affect the rate and extent of absorption of lipophilic drugs in particular. However, most PBPK models use fixed values of [BS] in fasted and fed states albeit with different values in different regions of the GI tract. During fasting, there is a relationship between gallbladder volume (GBV) and the phase of the Interdigestive Migrating Motor Complex cycle (IMMCc), showing cyclic GBV changes with periodic filling and emptying. This relationship is also affected by the origin of the IMMCc (antral or duodenal). In fed states, meta-analysis indicated that GB residual volume (% of fasting maximum) was 46.4 ± 27%CV and 30.7 ± 48%CV for low- and high-fat meals, respectively. The corresponding values for the duration of the emptying phase were for low fat meals 0.72h ± 1%CV and for high fat meals 1.17h ± 37%CV. The model, the Advanced Dynamic Bile Salt Model (ADBSM), was built bottom-up and its parameters were not fitted against in vivo measurements of [BS]. It involved update of the dynamic luminal fluid volumes model based on meta-analysis of available imaging data. The ADBSM is incorporated into the Simcyp (v18r2) PBPK simulator. The model predictivity was good (within 1.25-fold error for 11/20 of the clinical studies) and was assessed against clinical studies of luminal [BS] that provide only the type of meal (i.e., low- or high-fat), the timing of the meal and/or water intake events, and the number and age range of the study participants. The model is also an important component of models capturing enterohepatic recirculation of drug and metabolite. Further work is required to validate the current model and compare to simpler models with respect to drug absorption, especially of the lipophilic compounds.
Keywords: PBPK model; bile salts; biliary system; enterohepatic recirculation; gallbladder emptying; meta-analysis.
Similar articles
-
Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.AAPS J. 2018 Mar 29;20(3):57. doi: 10.1208/s12248-018-0217-6. AAPS J. 2018. PMID: 29600330
-
Neural modulation of canine duodenal bile acid delivery in the interdigestive and postprandial periods.Am J Physiol. 1993 Feb;264(2 Pt 1):G357-66. doi: 10.1152/ajpgi.1993.264.2.G357. Am J Physiol. 1993. PMID: 8447419
-
Regulation of fasting canine duodenal bile acid delivery by sphincter of Oddi and gallbladder.Am J Physiol. 1985 Nov;249(5 Pt 1):G622-33. doi: 10.1152/ajpgi.1985.249.5.G622. Am J Physiol. 1985. PMID: 4061650
-
Bile salts in digestion and transport of lipids.Adv Colloid Interface Sci. 2019 Dec;274:102045. doi: 10.1016/j.cis.2019.102045. Epub 2019 Oct 17. Adv Colloid Interface Sci. 2019. PMID: 31689682 Review.
-
PBPK models for the prediction of in vivo performance of oral dosage forms.Eur J Pharm Sci. 2014 Jun 16;57:300-21. doi: 10.1016/j.ejps.2013.09.008. Epub 2013 Sep 21. Eur J Pharm Sci. 2014. PMID: 24060672 Review.
Cited by
-
Gastrointestinal Bile Salt Concentrations in Healthy Adults Under Fasted and Fed Conditions: A Systematic Review and Meta-Analysis for Mechanistic Physiologically-Based Pharmacokinetic (PBPK) Modelling.AAPS J. 2025 Jan 22;27(1):31. doi: 10.1208/s12248-025-01016-x. AAPS J. 2025. PMID: 39843813
-
Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254).Pharmaceutics. 2023 Feb 3;15(2):521. doi: 10.3390/pharmaceutics15020521. Pharmaceutics. 2023. PMID: 36839843 Free PMC article.
-
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series.Pharmaceutics. 2022 May 7;14(5):1010. doi: 10.3390/pharmaceutics14051010. Pharmaceutics. 2022. PMID: 35631595 Free PMC article.
-
A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate.Mol Pharm. 2024 Sep 2;21(9):4510-4523. doi: 10.1021/acs.molpharmaceut.4c00424. Epub 2024 Jul 2. Mol Pharm. 2024. PMID: 38956965
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical